Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Non-pharmacological management of hypertension: in the light of current research

  • 1096 Accesses

  • 1 Citations


Hypertension is a major risk factor for a number of cardiovascular diseases. Proper management of hypertension may require both pharmacological and non-pharmacological interventions. Non-pharmacological interventions help reduce the daily dose of antihypertensive medication and delay the progression from prehypertension to hypertension stage. Non-pharmacological interventions include lifestyle modifications like dietary modifications, exercise, avoiding stress, and minimizing alcohol consumption. Nutritional requirements of hypertensive individuals can be addressed through adopting either the DASH diet or through traditional Mediterranean diet. These dietary guidelines promote the consumption of fruits, vegetables, grains, dairy products, and food rich in K+, Mg+2, Ca+2, and phosphorus. Restriction of Na+ intake has the greatest role in lowering the blood pressure. The DASH diet alone has the effect equal to that of a single drug therapy. After dietary modifications, exercise and weight loss are the second major intervention for hypertension management. Avoiding stressful lifestyle, depression, and anxiety also help to reduce elevated blood pressure. Minimizing alcohol intake also favors the blood pressure reduction. However, lifestyle modification is a dynamic process and requires continuous adherence. It is a multi-factorial approach targeting more than one intervention. However, 6–12-month lifestyle modifications can be attempted in stage-1 hypertensive patients without any cardiovascular complication, in the hope that they may be sufficiently effective to make it unnecessary to use medicines.

This is a preview of subscription content, log in to check access.


  1. 1.

    Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, Alexander L, Estep K, Abate KH, Akinyemiju TF (2017) Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015. JAMA 317(2):165–182

  2. 2.

    Council ES, Redon J, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Coca A, Olsen MH, Schmieder RE (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension. Eur Heart J 34:2159–2219

  3. 3.

    Selçuk KT, Çevik C, Mercan Y, Koca H (2017) Hypertensive patients’ adherence to pharmacological and non-pharmacological treatment methods, in Turkey. IJCMPH 4(8):2648–2657

  4. 4.

    Baena CP, Olandoski M, Younge JO, Buitrago-Lopez A, Darweesh SK, Campos N, Sedaghat S, Sajjad A, van Herpt TT, Freak-Poli R (2014) Effects of lifestyle-related interventions on blood pressure in low and middle-income countries: systematic review and meta-analysis. J Hypertens 32(5):961–973

  5. 5.

    Whelton PK, Appel L, Charleston J, Dalcin AT, Ewart C, Fried L, Kaidy D, Klag MJ, Kumanyika S, Steffen L (1992) The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the trials of hypertension prevention, phase I. JAMA 267(9):1213–1220

  6. 6.

    Azadbakht L, Fard NRP, Karimi M, Baghaei MH, Surkan PJ, Rahimi M, Esmaillzadeh A, Willett WC (2011) Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients. Diabetes Care 34(1):55–57

  7. 7.

    Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM (2006) Dietary approaches to prevent and treat hypertension. Hypertension 47(2):296–308

  8. 8.

    Saneei P, Salehi-Abargouei A, Esmaillzadeh A, Azadbakht L (2014) Influence of Dietary Approaches to Stop Hypertension (DASH) diet on blood pressure: a systematic review and meta-analysis on randomized controlled trials. Nutr Metab Cardiovasc Dis 24(12):1253–1261

  9. 9.

    Svetkey LP, Simons-Morton D, Vollmer WM, Appel LJ, Conlin PR, Ryan DH, Ard J, Kennedy BM (1999) Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med 159(3):285–293

  10. 10.

    Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM (1997) A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 336(16):1117–1124

  11. 11.

    Gay HC, Rao SG, Vaccarino V, Ali MK (2016) Effects of different dietary interventions on blood pressure. Hypertension HYPERTENSIONAHA 115.06853

  12. 12.

    Molitor J, Brown IJ, Chan Q, Papathomas M, Liverani S, Molitor N, Richardson S, Van Horn L, Daviglus ML, Dyer A (2014) Blood pressure differences associated with OMNIHEART-like diet compared to a typical American diet. Hypertension 64(6):1198–1204

  13. 13.

    Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, Miller ER, Conlin PR, Erlinger TP, Rosner BA, Laranjo NM (2005) Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. Jama 294(19):2455–2464

  14. 14.

    Blumenthal JA, Babyak MA, Hinderliter A, Watkins LL, Craighead L, Lin P-H, Caccia C, Johnson J, Waugh R, Sherwood A (2010) Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med 170(2):126–135

  15. 15.

    Trichopoulou A, Lagiou P (1997) Healthy traditional Mediterranean diet: an expression of culture, history, and lifestyle. Nutr Rev 55(11):383–389

  16. 16.

    Núñez-Córdoba JM, Valencia-Serrano F, Toledo E, Alonso A, Martínez-González MA (2008) The Mediterranean diet and incidence of hypertension: the Seguimiento Universidad de Navarra (SUN) Study. Am J Epidemiol 169(3):339–346

  17. 17.

    Kastorini C-M, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB (2011) The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 57(11):1299–1313

  18. 18.

    Simon G (2004) Pathogenesis of structural vascular changes in hypertension. J Hypertens 22(1):3–10

  19. 19.

    Van Horn L (2015) Dietary sodium and blood pressure: how low should we go? Prog Cardiovasc Dis 58(1):61–68

  20. 20.

    Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK (2007) Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 334(7599):885

  21. 21.

    Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton DG (2001) Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 344(1):3–10

  22. 22.

    Krishna GG, Miller E, Kapoor S (1989) Increased blood pressure during potassium depletion in normotensive men. N Engl J Med 320(18):1177–1182

  23. 23.

    Morris RC, Sebastian A, Forman A, Tanaka M, Schmidlin O (1999) Normotensive salt sensitivity. Hypertension 33(1):18–23

  24. 24.

    Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ (1997) Effects of oral potassium on blood pressure: meta-analysis of randomized controlled clinical trials. JAMA 277(20):1624–1632

  25. 25.

    Geleijnse JM, Kok FJ, Grobbee DE (2003) Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens 17(7):471–480

  26. 26.

    Grimm RH Jr, Neaton JD, Elmer PJ, Svendsen KH, Levin J, Segal M, Holland L, Witte LJ, Clearman DR, Kofron P (1990) The influence of oral potassium chloride on blood pressure in hypertensive men on a low-sodium diet. N Engl J Med 322(9):569–574

  27. 27.

    Ascherio A, Rimm EB, Giovannucci EL, Colditz GA, Rosner B, Willett WC, Sacks F, Stampfer MJ (1992) A prospective study of nutritional factors and hypertension among US men. Circulation 86(5):1475–1484

  28. 28.

    Tang H, Zhang X, Zhang J, Li Y, Del Gobbo LC, Zhai S, Song Y (2016) Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials. Diabetologia 59(12):2546–2551

  29. 29.

    Witteman JC, Willett WC, Stampfer MJ, Colditz GA, Sacks FM, Speizer FE, Rosner B, Hennekens CH (1989) A prospective study of nutritional factors and hypertension among US women. Circulation 80(5):1320–1327

  30. 30.

    Dyckner T, Wester P (1983) Effect of magnesium on blood pressure. Br Med J (Clin Res Ed) 286(6381):1847–1849

  31. 31.

    Lind L, Lithell H, Pollare T, Ljunghall S (1991) Blood pressure response during long-term treatment with magnesium is dependent on magnesium status: a double-blind, placebo-controlled study in essential hypertension and in subjects with high-normal blood pressure. Am J Hypertens 4(8):674–679

  32. 32.

    van Mierlo LA, Arends LR, Streppel MT, Zeegers M, Kok FJ, Grobbee DE, Geleijnse JM (2006) Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J Hum Hypertens 20(8):571–580

  33. 33.

    Yagi S, Aihara K-i, Kondo T, Endo I, Hotchi J, Ise T, Iwase T, Akaike M, Matsumoto T, Sata M (2014) High serum parathyroid hormone and calcium are risk factors for hypertension in Japanese patients. Endocr J 61(7):727–733

  34. 34.

    Park J, Lee J-S, Kim J (2010) Relationship between dietary sodium, potassium, and calcium, anthropometric indexes, and blood pressure in young and middle aged Korean adults. NRP 4(2):155–162

  35. 35.

    Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L (2010) Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev, 8 (8)

  36. 36.

    Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D’Agostino RB, Wolf M, Vasan RS (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117(4):503–511

  37. 37.

    Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, Curhan GC (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49(5):1063–1069

  38. 38.

    Chitalia N, Recio-Mayoral A, Kaski JC, Banerjee D (2012) Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients. Atherosclerosis 220(1):265–268

  39. 39.

    Zhang Q-Y, Jiang C-M, Sun C, Tang T-F, Jin B, Cao D-W, He J-S, Zhang M (2015) Hypovitaminosis D is associated with endothelial dysfunction in patients with non-dialysis chronic kidney disease. J Nephrol 28(4):471–476

  40. 40.

    Witham M, Dove F, Dryburgh M, Sugden J, Morris A, Struthers A (2010) The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 53(10):2112–2119

  41. 41.

    Sugden J, Davies J, Witham M, Morris A, Struthers A (2008) Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med 25(3):320–325

  42. 42.

    Witham MD, Ireland S, Houston JG, Gandy SJ, Waugh S, MacDonald TM, Mackenzie IS, Struthers AD (2014) Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trial. Hypertension 63(4):706–712

  43. 43.

    Scragg R, Slow S, Stewart AW, Jennings LC, Chambers ST, Priest PC, Florkowski CM, Camargo CA Jr, Murdoch DR (2014) Long-term high-dose vitamin D3 supplementation and blood pressure in healthy adults: a randomized controlled trial. Hypertension 64(4):725–730

  44. 44.

    Forman JP, Scott JB, Ng K, Drake BF, Suarez EG, Hayden DL, Bennett GG, Chandler PD, Hollis BW, Emmons KM (2013) Effect of vitamin D supplementation on blood pressure in blacks. Hypertension 61(4):779–785

  45. 45.

    Alderman MH (1994) Non-pharmacological treatment of hypertension. Lancet 344(8918):307–311

  46. 46.

    Puddey IB, Beilin LJ, Vandongen R (1987) Regular alcohol use raises blood pressure in treated hypertensive subjects: a randomised controlled trial. Lancet 329(8534):647–651

  47. 47.

    Xin X, He J, Frontini MG, Ogden LG, Motsamai OI, Whelton PK (2001) Effects of alcohol reduction on blood pressure. Hypertension 38(5):1112–1117

  48. 48.

    Ohira T, Tanigawa T, Tabata M, Imano H, Kitamura A, Kiyama M, Sato S, Okamura T, Cui R, Koike KA (2009) Effects of habitual alcohol intake on ambulatory blood pressure, heart rate, and its variability among Japanese men. Hypertension 53(1):13–19

  49. 49.

    Abramson JL, Lewis C, Murrah NV (2010) Relationship of self-reported alcohol consumption to ambulatory blood pressure in a sample of healthy adults. Am J Hypertens 23(9):994–999

  50. 50.

    Roerecke M et al (2014) The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. The Lancet Public Health 2.2:e108–e120

  51. 51.

    Arkwright PD, Beilin LJ, Rouse I, Armstrong BK, Vandongen R (1982) Effects of alcohol use and other aspects of lifestyle on blood pressure levels and prevalence of hypertension in a working population. Circulation 66(1):60–66

  52. 52.

    Nanchahal K, Ashton WD, Wood DA (2000) Alcohol consumption, metabolic cardiovascular risk factors and hypertension in women. Int J Epidemiol 29(1):57–64

  53. 53.

    Cushman WC, Cutler JA, Hanna E, Bingham SF, Follmann D, Harford T, Dubbert P, Allender PS, Dufour M, Collins JF (1998) Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressure. Arch Intern Med 158(11):1197–1207

  54. 54.

    Aygen B (2015) Effects of alcohol consumption on hypertension. Turgut Özal Tıp Merkezi Dergisi, 22 (2)

  55. 55.

    Faselis C, Doumas M, Kokkinos JP, Panagiotakos D, Kheirbek R, Sheriff HM, Hare K, Papademetriou V, Fletcher R, Kokkinos P (2012) Exercise capacity and progression from prehypertension to hypertension novelty and significance. Hypertension 60(2):333–338

  56. 56.

    Whelton SP, Chin A, Xin X, He J (2002) Effect of aerobic exercise on blood pressurea meta-analysis of randomized, controlled trials. Ann Intern Med 136(7):493–503

  57. 57.

    Cornelissen VA, Fagard RH, Coeckelberghs E, Vanhees L (2011) Impact of resistance training on blood pressure and other cardiovascular risk factors. Hypertension, HYPERTENSIONAHA. 111.177071

  58. 58.

    Pescatello LS, Kulikowich JM (2001) The aftereffects of dynamic exercise on ambulatory blood pressure. Med Sci Sports Exerc 33(11):1855–1861

  59. 59.

    Kelley GA, Kelley KS (2000) Progressive resistance exercise and resting blood pressure. Hypertension 35(3):838–843

  60. 60.

    Zago AS, Silveira LR, Kokubun E (2010) Effects of aerobic exercise on the blood pressure, oxidative stress and eNOS gene polymorphism in pre-hypertensive older people. Eur J Appl Physiol 110(4):825–832

  61. 61.

    Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, Kumanyika S, Lacy CR, Johnson KC, Folmar S (1998) Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA 279(11):839–846

  62. 62.

    Group, T. o. H. P. C. R (1997) Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in over-weight people with high normal blood pressure: the trials of hypertension prevention, phase II. Arch Intern Med 157:657–667

  63. 63.

    Miller ER, Erlinger TP, Young DR, Jehn M, Charleston J, Rhodes D, Wasan SK, Appel LJ (2002) Results of the diet, exercise, and weight loss intervention trial (DEW-IT). Hypertension 40(5):612–618

  64. 64.

    Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, Stevens VJ, Vollmer WM, Lin P-H, Svetkey LP (2003) Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA

  65. 65.

    Sparrenberger F, Cichelero F, Ascoli A, Fonseca F, Weiss G, Berwanger O, Fuchs S, Moreira L, Fuchs F (2009) Does psychosocial stress cause hypertension? A systematic review of observational studies. J Hum Hypertens 23(1):12–19

  66. 66.

    Caspi A, Harrington H, Moffitt TE, Milne BJ, Poulton R (2006) Socially isolated children 20 years later: risk of cardiovascular disease. Arch Pediatr Adolesc Med 160(8):805–811

  67. 67.

    Riley EH, Wright RJ, Jun H-J, Hibert EN, Rich-Edwards JW (2010) Hypertension in adult survivors of child abuse: observations from the Nurses’ Health Study II. J Epidemiol Community Health 64(5):413–418

  68. 68.

    Malzberg B (1937) Mortality among patients with involution melancholia. Am J Psychiatr 93(5):1231–1238

  69. 69.

    Leor J, Poole WK, Kloner RA (1996) Sudden cardiac death triggered by an earthquake. N Engl J Med 334(7):413–419

  70. 70.

    Wilbert-Lampen U, Leistner D, Greven S, Pohl T, Sper S, Völker C, Güthlin D, Plasse A, Knez A, Küchenhoff H (2008) Cardiovascular events during World Cup soccer. N Engl J Med 358(5):475–483

  71. 71.

    Grassi G (2009) Assessment of sympathetic cardiovascular drive in human hypertension. Hypertension 54(4):690–697

  72. 72.

    Jonatan YE, Widayanti JR (2017) 61 The Association of Hypertension with Depression, Anxiety and Stress Score in Atma Jaya Hospital. J Hypertens 35:e9

  73. 73.

    Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, Flack JM, Carter BL, Materson BJ, Ram CVS (2014) Clinical practice guidelines for the management of hypertension in the community. J Clin Hypertens 16(1):14–26

  74. 74.

    Pimenta E, Oparil S (2010) Prehypertension: epidemiology, consequences and treatment. Nat Rev Nephrol 6(1):21–30

Download references

Author information

Correspondence to Kifayat Ullah Shah.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mahmood, S., Shah, K.U., Khan, T.M. et al. Non-pharmacological management of hypertension: in the light of current research. Ir J Med Sci 188, 437–452 (2019).

Download citation


  • DASH diet
  • Exercise
  • Hypertension
  • Lifestyle modifications
  • Low salt diet
  • Non-pharmacological management